OraSure Technologies, Inc.

NASDAQ:OSUR

Medical - Instruments & Supplies

Healthcare
$3.59 -3.47%

-$0.16 today

Market cap
$247.88M
Beta
1.01
P/E (TTM)
-4.0
EPS (TTM)
-$1.08
52W Low $2.08High $4.58

Volume 0.49M

Average 0.61M

OSUR Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

OraSure Technologies, Inc.NASDAQ: OSUR

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses declines year over year

Q1 FY2026 other income / expenses of $367K fell 79.3% year over year, ahead of the -104.2% change in trailing-twelve-month other income / expenses.

Context

  • Other income / expenses amounted to 1.0% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -79.3% holds above the trailing-twelve-month pace of -104.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$367K+116.5% QoQ
Last fiscal yearDec 2025
$1.19M-58.8% YoY
LTMMar 2026
-$208K-104.2% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-79.3%——
1 year-58.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
1.19M USD
Year-over-year change
-58.8%
4-year CAGR
-15.6%

Other Income / Expenses vs competitors

How OSUR compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -104.2% is the 8th highest of 9, against a peer median of -21.4%.
  • Other income / expenses amounts to 0.2% of revenue for OSUR, versus a peer median of 7.3%.
OSUR Competitors
Other Income / Expenses for OSUR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CATXPerspective Therapeutics, Inc.LTM Mar 2026$7.57M USD-41.2%+161.3%1225.4%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$7.03M USD-30.0%+11.2%—
TARAProtara Therapeutics, Inc.LTM Mar 2026$6.75M USD+12.2%+85.7%—
UTMDUtah Medical Products, Inc.LTM Mar 2026$2.62M USD-12.7%+46.1%7.0%
NYXHNyxoah S.A.LTM Mar 2026€1.25M EUR+265.9%—7.6%
OSUROraSure Technologies, Inc.LTM Mar 2026-$208K USD-104.2%—0.2%
PROFProfound Medical Corp.LTM Mar 2026-$611.96K USD-101.2%—3.2%
NTHINeonc Technologies Holdings, Inc.LTM Mar 2026-$5.24M USD———
STIMNeuronetics, Inc.LTM Mar 2026-$7.83M USD+20.6%—5.2%
PREPrenetics Global LimitedLTM Mar 2026-$35.09M USD-262.9%—30.8%
Peer median (excluding OSUR) —-21.4%+65.9%7.3%

Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue233.67M387.48M405.47M185.83M115.02M
Cost of Revenue116.07M239.04M226.05M109.6M66.82M
Gross Profit117.6M148.44M179.42M76.23M48.2M
Gross Margin50.3%38.3%44.2%41.0%41.9%
Research & Development34.17M36.24M33.16M24.42M42.53M
Selling, General & Admin95.08M117.44M92.18M72.41M73.79M
Operating Expenses129.25M153.68M125.34M96.83M116.32M
Depreciation & Amortization11.66M14M19.9M10.87M9.97M
EBITDA2.37M(1.68M)76.16M(6.83M)(56.96M)
EBITDA Margin1.0%-0.4%18.8%-3.7%-49.5%
Operating Income(11.65M)(5.24M)54.08M(20.6M)(68.12M)
Operating Margin-5.0%-1.4%13.3%-11.1%-59.2%
Interest Income00000
Interest Expense00000
Other Income / Expenses2.36M(10.43M)2.18M2.9M1.19M
Income Before Tax(9.29M)(15.68M)56.26M(17.7M)(66.93M)
Pre-Tax Margin-4.0%-4.0%13.9%-9.5%-58.2%
Income Tax Expense13.71M1.46M2.6M1.8M1.8M
Net Income(23M)(17.13M)53.66M(19.5M)(68.73M)
Net Margin-9.8%-4.4%13.2%-10.5%-59.8%
EPS (Basic)(0.32)(0.25)0.73(0.26)(0.94)
EPS (Diluted)(0.32)(0.25)0.72(0.26)(0.94)
Weighted Avg Shares71.98M72.51M73.35M74.43M73.49M
Weighted Avg Shares (Diluted)71.98M72.51M74.39M74.43M73.49M

OraSure Technologies, Inc.

NASDAQ:OSUR

Intrinsic Alpha fair value

Locked

Current Price

$3.59

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.